We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAR icon
926
Darling Ingredients
DAR
$9.99B
$208K 0.02%
+6,728
New +$225K
CROX icon
927
Crocs
CROX
$6.63B
$208K 0.02%
+2,484
New +$227K
ANDE icon
928
Andersons Inc
ANDE
$2.23B
$208K 0.02%
+5,213
New +$201K
CR icon
929
Crane Co
CR
$12.7B
$208K 0.02%
+1,127
New +$213K
WULF icon
930
CALL
TeraWulf
WULF
$8.08B
$207K 0.02%
+2,300
New +$17.6K
ECG
931
Everus Construction Group
ECG
$6.73B
$206K 0.02%
+2,403
New +$179K
AIOT
932
PowerFleet Inc
AIOT
$411M
$206K 0.02%
39,320
-10,548
-21% -$48.7K
BJRI icon
933
BJ's Restaurants
BJRI
$1.46B
$205K 0.02%
+6,722
New +$240K
AMAL icon
934
Amalgamated Financial
AMAL
$1.48B
$205K 0.02%
+7,550
New +$224K
CHRW icon
935
C.H. Robinson
CHRW
$17.3B
$205K 0.02%
+1,545
New +$181K
PBYI icon
936
Puma Biotechnology
PBYI
$442M
$204K 0.02%
38,422
+5,000
+15% +$21.2K
COYA icon
937
Coya Therapeutics
COYA
$109M
$204K 0.02%
35,770
NTRS icon
938
Northern Trust
NTRS
$34.4B
$203K 0.02%
+1,511
New +$194K
HPE icon
939
Hewlett Packard
HPE
$72.4B
$203K 0.02%
+8,267
New +$183K
IR icon
940
Ingersoll Rand
IR
$33.6B
$203K 0.02%
+2,457
New +$201K
PGR icon
941
Progressive
PGR
$124B
$203K 0.02%
821
-520
-39% -$128K
ASLE icon
942
AerSale
ASLE
$274M
$202K 0.02%
+24,700
New +$186K
MCHI icon
943
iShares MSCI China ETF
MCHI
$6.42B
$202K 0.02%
3,069
-658
-18% -$39.4K
GTLB icon
944
GitLab
GTLB
$6.88B
$202K 0.02%
+4,479
New +$205K
CRNC icon
945
Cerence
CRNC
$403M
$202K 0.02%
+16,192
New +$166K
URBN icon
946
Urban Outfitters
URBN
$6.81B
$202K 0.02%
+2,823
New +$208K
CORZ icon
947
CALL
Core Scientific
CORZ
$6.25B
$201K 0.02%
+1,125
New +$16.5K
ZBRA icon
948
Zebra Technologies
ZBRA
$17.9B
$201K 0.02%
+677
New +$216K
GPOR icon
949
Gulfport Energy Corp
GPOR
$2.97B
$201K 0.02%
+1,111
New +$193K
UTZ icon
950
Utz Brands
UTZ
$1.25B
$200K 0.02%
+16,497
New +$219K

Similar funds

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.